Cargando…

Blood–Brain Barrier Disruption Is Not Associated With Disease Aggressiveness in Amyotrophic Lateral Sclerosis

The pathogenesis of the fatal neurodegenerative condition amyotrophic lateral sclerosis (ALS) remains to be fully understood. Blood–brain barrier damage (BBBD) has been implicated as an exacerbating factor in several neurodegenerative conditions, including ALS. Therefore, this cross-sectional study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prell, Tino, Vlad, Benjamin, Gaur, Nayana, Stubendorff, Beatrice, Grosskreutz, Julian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586537/ https://www.ncbi.nlm.nih.gov/pubmed/34776835 http://dx.doi.org/10.3389/fnins.2021.656456

Ejemplares similares

Reaction to Endoplasmic Reticulum Stress via ATF6 in Amyotrophic Lateral Sclerosis Deteriorates With Aging
por: Prell, Tino, et al.
Publicado: (2019)

Cerebrospinal Fluid Neurofilament Light Chain (NfL) Predicts Disease Aggressiveness in Amyotrophic Lateral Sclerosis: An Application of the D50 Disease Progression Model
por: Dreger, Marie, et al.
Publicado: (2021)

Triage of Amyotrophic Lateral Sclerosis Patients during the COVID-19 Pandemic: An Application of the D50 Model
por: Steinbach, Robert, et al.
Publicado: (2020)

Applying the D50 disease progression model to gray and white matter pathology in amyotrophic lateral sclerosis
por: Steinbach, Robert, et al.
Publicado: (2019)

Developing a Neuroimaging Biomarker for Amyotrophic Lateral Sclerosis: Multi-Center Data Sharing and the Road to a “Global Cohort”
por: Steinbach, Robert, et al.
Publicado: (2018)

Disease aggressiveness signatures of amyotrophic lateral sclerosis in white matter tracts revealed by the D50 disease progression model
por: Steinbach, Robert, et al.
Publicado: (2020)

The ER mitochondria calcium cycle and ER stress response as therapeutic targets in amyotrophic lateral sclerosis
por: Tadic, Vedrana, et al.
Publicado: (2014)

Use of vitamins by participants in amyotrophic lateral sclerosis clinical trials
por: Prell, Tino, et al.
Publicado: (2020)

Modelling disease course in amyotrophic lateral Sclerosis: pseudo-longitudinal insights from cross-sectional health-related quality of life data
por: Prell, Tino, et al.
Publicado: (2020)

Assessment of pulmonary function in amyotrophic lateral sclerosis: when can polygraphy help evaluate the need for non-invasive ventilation?
por: Prell, Tino, et al.
Publicado: (2016)

Monocyte-Derived Macrophages Contribute to Chitinase Dysregulation in Amyotrophic Lateral Sclerosis: A Pilot Study
por: Gaur, Nayana, et al.
Publicado: (2021)

Patterns of grey and white matter changes differ between bulbar and limb onset amyotrophic lateral sclerosis
por: Steinbach, Robert, et al.
Publicado: (2021)

The Chitinases as Biomarkers for Amyotrophic Lateral Sclerosis: Signals From the CNS and Beyond
por: Gaur, Nayana, et al.
Publicado: (2020)

Longitudinal diffusion tensor imaging in amyotrophic lateral sclerosis
por: Keil, Carsten, et al.
Publicado: (2012)

Poor emotional well-being is associated with rapid progression in amyotrophic lateral sclerosis
por: Prell, Tino, et al.
Publicado: (2019)

Cortical and subcortical grey matter atrophy in Amyotrophic Lateral Sclerosis correlates with measures of disease accumulation independent of disease aggressiveness
por: Dieckmann, Nora, et al.
Publicado: (2022)

Amyotrophic Lateral Sclerosis: Advances and Prospects
por: Boentert, Matthias, et al.
Publicado: (2023)

Voxel-Based MRI Intensitometry Reveals Extent of Cerebral White Matter Pathology in Amyotrophic Lateral Sclerosis
por: Hartung, Viktor, et al.
Publicado: (2014)

Susceptibility-Weighted Imaging Provides Insight into White Matter Damage in Amyotrophic Lateral Sclerosis
por: Prell, Tino, et al.
Publicado: (2015)

Potential Preventive Strategies for Amyotrophic Lateral Sclerosis
por: Kuraszkiewicz, B., et al.
Publicado: (2020)

Neuroimaging Endpoints in Amyotrophic Lateral Sclerosis
por: Menke, Ricarda A. L., et al.
Publicado: (2016)

Breached Barriers: A Scoping Review of Blood-Central Nervous System Barrier Pathology in Amyotrophic Lateral Sclerosis
por: Mirian, Ario, et al.
Publicado: (2022)

Classification of amyotrophic lateral sclerosis by brain volume, connectivity, and network dynamics
por: Thome, Janine, et al.
Publicado: (2021)

Widespread sensorimotor and frontal cortical atrophy in Amyotrophic Lateral Sclerosis
por: Grosskreutz, Julian, et al.
Publicado: (2006)

Cerebrospinal fluid biomarkers of disease activity and progression in amyotrophic lateral sclerosis
por: Dreger, Marie, et al.
Publicado: (2022)

Dysregulation of chemokine receptor expression and function in leukocytes from ALS patients
por: Perner, Caroline, et al.
Publicado: (2018)

Disrupted neuronal trafficking in amyotrophic lateral sclerosis
por: Burk, Katja, et al.
Publicado: (2019)

Sleep and Sleep Disruption in Amyotrophic Lateral Sclerosis
por: Boentert, Matthias
Publicado: (2020)

Motoneuron firing in amyotrophic lateral sclerosis (ALS)
por: de Carvalho, Mamede, et al.
Publicado: (2014)

Miro1 deficiency in amyotrophic lateral sclerosis
por: Zhang, Fan, et al.
Publicado: (2015)

Mitochondrial dynamism and the pathogenesis of Amyotrophic Lateral Sclerosis
por: Cozzolino, Mauro, et al.
Publicado: (2015)

Laryngeal Sensitivity in Patients with Amyotrophic Lateral Sclerosis
por: Ruoppolo, Giovanni, et al.
Publicado: (2016)

Role of Extracellular Vesicles in Amyotrophic Lateral Sclerosis
por: Ferrara, Deborah, et al.
Publicado: (2018)

Stress Granule Dysregulation in Amyotrophic Lateral Sclerosis
por: Dudman, Jessica, et al.
Publicado: (2020)

Basal ganglia alterations in amyotrophic lateral sclerosis
por: Castelnovo, Veronica, et al.
Publicado: (2023)

Extent of cortical involvement in amyotrophic lateral sclerosis – an analysis based on cortical thickness
por: Thorns, Johannes, et al.
Publicado: (2013)

Cognitive, Emotional and Psychological Manifestations in Amyotrophic Lateral Sclerosis at Baseline and Overtime: A Review
por: Benbrika, Soumia, et al.
Publicado: (2019)

Amyotrophic lateral sclerosis: a dying motor unit?
por: Piotrkiewicz, Maria, et al.
Publicado: (2013)

Are There Modifiable Environmental Factors Related to Amyotrophic Lateral Sclerosis?
por: Kuraszkiewicz, Bozenna, et al.
Publicado: (2018)

Abnormal Functional Connectivity Density in Amyotrophic Lateral Sclerosis
por: Li, Weina, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_eric6jnhjcutckejuvjor36tah